Christopher Malinky, MD
Pain Medicine · Colorado Springs, CONPI 1669638144
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,676 of the $4,951 with a category attached, or 74.2%. 21 manufacturers reported payments, led by Boston Scientific at 57.4% of the total.
Across 183 payments — averaging $27.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Tersera Therapeutics LLC$355
- Abbott$316
- Medtronic$309
- Si-bone, Inc.$168
- Collegium Pharmaceutical, Inc.$131
- plus $829 from 15 others
What the payments were for
- Consulting fees$1,27526%
- Food & beverage$3,67674%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 70 | $2,843 |
| Tersera Therapeutics LLC | 17 | $355 |
| Abbott | 14 | $316 |
| Medtronic(2 entities) | 20 | $309 |
| Si-bone, Inc. | 8 | $168 |
| Collegium Pharmaceutical, Inc. | 9 | $131 |
| Vertos Medical, Inc. | 7 | $124 |
| Painteq LLC | 2 | $123 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $119 |
| AbbVie(2 entities) | 5 | $94 |
| Pfizer | 4 | $76 |
| Nalu Medical, Inc. | 5 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 3 | $38 |
| Nevro Corp. | 1 | $27 |
| Sentynl Therapeutics, Inc. | 2 | $26 |
| IBSA Pharma Inc. | 1 | $21 |
| Vertex | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,951 in reported general payments places this provider in the 65th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 44 | $17,832 |
| OxycontinOxycodone Hcl | 18 | $16,118 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 73 | $2,278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 125 | $2,147 |
| Oxycodone Hcl | 147 | $2,129 |
| Pregabalin | 41 | $1,249 |
| Gabapentin | 64 | $1,005 |
| Morphine Sulfate | 26 | $936 |
| Morphine Sulfate ErMorphine Sulfate | 31 | $683 |
| Methadone Hcl | 27 | $526 |
| Tramadol Hcl | 58 | $399 |
| Mupirocin | 41 | $376 |
| Celecoxib | 20 | $318 |
| Tizanidine Hcl | 17 | $228 |
| Cyclobenzaprine Hcl | 20 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $131 | $17,83244 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 96 pain medicine providers in Colorado.
Other pain medicine in Colorado Springs
- Mark MeyerColorado Springs$14K
- Jennifer WindsorColorado Springs$9K
- Zachary WinklerColorado Springs$9K
- Vladislav SuntsovColorado Springs$9K
- Joshua RockColorado Springs$9K
- Anthony NguyenColorado Springs$7K
- Morgan DahmsColorado Springs$5K
- Tyler NickleColorado Springs$4K
- William LippertColorado Springs$3K
- Timothy SandellColorado Springs$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.